Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
3.100
+0.130 (4.38%)
At close: Jun 29, 2026, 4:00 PM EDT
3.160
+0.060 (1.94%)
Pre-market: Jun 30, 2026, 4:47 AM EDT
Psyence Biomedical Market Cap
Psyence Biomedical has a market cap or net worth of $11.82 million as of June 30, 2026. Its market cap has increased by 307.91% in one year.
Market Cap
11.82M
Enterprise Value
4.38M
1-Year Change
307.91%
Ranking
Category
Stock Price
$3.10
Market Cap Chart
Since December 10, 2021, Psyence Biomedical's market cap has decreased from $323.44M to $11.82M, a decrease of -96.34%. That is a compound annual growth rate of -51.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 11.82M | 738.37% |
| Dec 31, 2025 | 1.41M | -84.90% |
| Dec 31, 2024 | 9.34M | -88.49% |
| Dec 29, 2023 | 81.16M | -75.84% |
| Dec 30, 2022 | 335.86M | 3.73% |
| Dec 31, 2021 | 323.77M | 0.10% |
| Dec 10, 2021 | 323.44M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SeaStar Medical Holding | 13.11M |
| BioLineRx | 13.11M |
| Traws Pharma | 12.36M |
| Akari Therapeutics, | 12.03M |
| CytoMed Therapeutics | 11.71M |
| OSR Health | 11.71M |
| Chemomab Therapeutics | 11.52M |
| Theriva Biologics | 11.51M |